Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series.
Título
Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series.
Autor
Stephen Su Yang, Rosa Boudjemai, Jed Lipes
Fecha
2021
Identificador
10.1053/j.jvca.2020.10.040
Fuente
Journal of cardiothoracic and vascular anesthesia
Archivos
Colección
Citación
Stephen Su Yang, Rosa Boudjemai, Jed Lipes, “Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series.,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/8092.
Position: 13036 (22 views)